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INTRODUCTION:  Malignant  melanoma  is  one  of  the most  rapidly  increasing  cancer  in  the  world.  Breast
metastases  from  melanoma  are  uncommon  but  could  reﬂect  a  widespread  disease.
PRESENTATION OF  CASE:  We  report  a case of  malignant  widespread  melanoma  presenting  with  bilat-
eral  breast  nodules  in  a 39 year-old  pre-menopausal  Caucasian  woman  with  an  history  of  cutaneous
melanoma  of the  trunk.  Breast  clinical  examination  revealed  the  presence  of a  hard  and  mobile  lump
located  on  the left  breast.  Ultrasound  detected  two  bilateral  nodules  corresponding  to oval  opacities
with  well-deﬁned  edges  and  without  calciﬁcations  or architectural  distortion  on  mammography.  Fine
needle  aspiration  cytology  performed  on both  breast  nodules  conﬁrmed  that  the  breast lesions  were
metastases  from  primary  cutaneous  malignant  melanoma.  A  total-body  CT  examination  detected  brain,
lung  and  abdominal  lymph  nodes  metastases.
DISCUSSION: The  breast  represents  an uncommon  site  of  metastatic  disease  from  extra-mammary
tumors.  Imaging  features  of  breast  metastases  from  melanoma  usually  do  not  allow  a  differential
diagnosis  with  breast  primary  tumors.  Breast  metastases  may  be asymptomatic  or palpable  as dense
and  well-circumscribed  nodules.  Breast  metastases  indicate  a widespread  disease  and  should  lead  to
avoid  aggressive  surgical  procedures  because  of  the  poor  prognosis  of  patients  affected  by metastatic
melanoma.
CONCLUSION:  The  detection  of  bilateral  breast  metastases  from  melanoma  is  highly  suggestive  of
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. Introduction
Malignant melanoma is one of the most rapidly increasing can-
er in the world with an increasing incidence rate in recent decades.
n estimated 76,250 new melanoma cases have been diagnosed in
he United States in 2012 and 9180 are expected to die.1
Haematic or lymphatic metastases from malignant melanoma
ccur outes in 20% of cases. Liver, lung and brain represent the
ommon sites of haematic metastases, although any organ could
e involved. Metastases to the breast from malignant melanoma
r other extra-mammary tumors are rare and represent approx-
mately 1.3–2.7% of all malignant breast tumors. Melanomas and
Open access under CC BY-NC-Nymphomas are the most commonly reported tumors metas-
asizing to the breast. Breast involvement often represents the
rst sign of a primary extra-mammary tumor.1–4 For this reason,
reast metastases must be suspected in patients with an history
f malignant melanoma and the detection of breast lesions always
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requires further diagnostic and instrumental procedures aimed to
their characterization. Even if breast metastases from melanoma
have no speciﬁc feature on imaging techniques, cytological or
histological examination provides crucial information in order to
choose the most suitable therapeutic approach.
In this paper, we report the case of a pre-menopausal woman
with an history of malignant cutaneous melanoma of the trunk and
a palpable left breast lump 3 years later. The diagnostic and instru-
mental procedures revealed metastases to the breast and others
organs from malignant melanoma.
2. Presentation of case
A  39 year-old pre-menopausal Caucasian woman was referred
to our breast clinical center for a palpable lump on left breast.
The  patient had an history of a primary cutaneous melanoma
of the trunk diagnosed at the age of 36. In December 2009, the
lesion was surgically removed from the inter-scapular region and
the histo-pathological examination revealed a Superﬁcial Spread-
ing Malignant Melanoma (SSMM)  with inﬁltration of the reticular
derma and a thickness of 2.8 mm,  Clark IV. The excision margins
se.were not inﬁltrated. A wide local and sentinel lymph node excisions
were performed in the region of the nape and of the trapezius. The
histological report was  negative for tissue and node involvement.
No  further treatment was performed for this disease.
s Ltd.  Open access under CC BY-NC-ND license.
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Fig. 1. A and B US examination. Two  breast hypo-echoic nodules with regular edges were detected in the superior medial quadrant of the left breast (A, arrow) and on the
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fnferior inner quadrant of the right breast (B, arrow), respectively. B and C CT sca
ppearing as hyper-enhanced lesions. An excavate lung metastasis was  also eviden
In December 2012, the patient felt a lump on the left breast.
reast clinical examination conﬁrmed the presence of a hard and
obile lump with normal overlying skin located in the supe-
ior medial quadrant of the left breast. Ultrasound detected two
ilateral rounded nodules with well-deﬁned edges, hypo-echoic
tructure and a maximum diameter of 1.4 cm.
The  nodules appeared as oval opacities with well-deﬁned edges
nd without calciﬁcations or architectural distortion on mammog-
aphy.
A ﬁne needle aspiration cytology (FNAC) was  performed on
oth breast nodules by using a 21G needle. The sample mate-
ial was macroscopically dark and therefore highly suggestive
f melanocytic pigmentation. The cytological and immuno-histo-
hemical reports (S100 protein, Melan-A and HMB-45) diagnosed
etastases from primary cutaneous malignant melanoma.
A  total-body CT examination was performed a week later.
rain, lung and abdominal lymph nodes metastases were detected
Figs. 1 and 2).
The  patient underwent whole brain radiation therapy for brain
etastasis (30 Gy in 10 fractions) and she is now undergoing a tar-
et drug therapy with Dabrafenib, a reversible selective inhibitor
f mutant BRAF.
ig. 2. CT scans. (A) Multiple brain metastases were detected in both cerebral hemisphe
rom cutaneous malignant melanoma (arrow).rresponding CT ﬁndings of the left (C, arrow) and right (D, arrow) breast nodules
e upper lobe of the right lung (C, arrow head).
3. Discussion
Breast represents an uncommon site of metastatic disease from
extra-mammary tumors. The most common primary tumor sources
for breast metastases are represented by lymphomas, melanomas,
rhabdomyosarcomas, lung and ovarian tumors.1,2 Patients with
breast metastases from melanoma are often pre-menopausal
women and considerably younger than patients affected by other
tumors with breast metastatic involvement. In about 50% of cases,
the upper outer quadrant is involved.2,4–8 The age and hormonal
setting of our patient seem to conﬁrm these previously reported
ﬁndings, except for the site of breast lesions, located in the superior
medial quadrant of the left breast and in the inferior inner quadrant
of the right breast.
Besides,  in case of breast metastases from cutaneous malignant
melanoma, the most common Clark stage reported at diagnosis is
IV, 2–3 mm of depth by Breslow and the mean reported interval
from the initial diagnosis is 33 months.
As reported by Majeski, the bilateral breast involvement
amounts  for about 10% of patients affected by breast metastases
from melanoma and suggests a widely disseminated disease as a
poor prognostic factor.1
res (arrow). (B) CT image on the coronal plane showing multiple lung metastases
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The clinical examination and imaging features of breast metas-
ases from melanoma usually do not allow a differential diagnosis
ith breast primary tumors. Breast metastases may  be asymp-
omatic or palpable as dense and well-circumscribed nodules.
n ultrasound examination, lesions usually appear as rounded or
val hypo-echoic nodules with a well-deﬁned posterior wall. On
ammography, breast metastases appear as well-deﬁned nodular
pacities without calciﬁcations or architectural distortion.1–3
For these reasons, clinical history, cytological and histological
xaminations are crucial for diagnosis.
In our experience, the history of malignant melanoma and the
igmented cytological samples were highly suggestive of breast
etastases, therefore histological examination was  not required.
owever, melanin pigment within tumor cells represents a rare
eature. In fact, in most cases, metastatic melanoma can mimic  a
ariety of cellular and architecture phenotypes, including primary
reast malignancies. Immuno-histo-chemistry allows a correct
iagnosis; tumor cell immune-reactivity for S100 protein, Melan-
 and HMB-45, along with no expression for cytokeratin staining,
roves useful in differentiating malignant melanoma from other
alignant tumors.8,9
The diagnosis of breast metastases from melanoma, especially in
ase of bilateral lesions, requires a whole body evaluation because
n most cases they are associated with wide dissemination.
Treatment options for metastatic melanoma include close
bservation, surgical resection of isolated metastases, chemother-
py and radiation therapy.
With  regard to chemotherapy, the response rates to dacarbazine
nd interleukin (IL-2) therapy are low. However, the treatment of
etastatic melanoma has been modiﬁed by the introduction of tar-
eted therapy and immunotherapy; in fact, vemurafenib, a BRAF
nhibitor, and ipilimumab, an anti-cytotoxic T-lymphocyte anti-
en 4 antibody, represent the ﬁrst agents which showed a survival
eneﬁt.
Radiation therapy plays a limited role in the control of the nat-
ral history of metastatic melanoma, because the radio-sensitivity
f melanoma cells is low.1,4,9,10 Our patient underwent whole brain
adiation therapy because of the presence of multiple brain metas-
ases.
Finally, breast metastases indicate a widespread disease and
hould lead to avoid aggressive surgical procedures because of the
oor prognosis of patients affected by metastatic melanoma..  Conclusion
Metastases to the breast should be searched in any patient with
n history of cutaneous malignant melanoma and suspected in
1
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case  of breast lumps. Any breast lump in these patients should be
characterized by cytological or histological examination. In case
of conﬁrmed breast metastases from melanoma, no therapeutic
approach should be performed before the staging of the disease.
In fact, breast metastases could reﬂect a widespread disease and a
poor prognosis, especially in case of bilateral breast lesions.
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